A further report on the function of KCa3.1 in glioma therapy resistance suggests a direct inhibition of the channel by TMZ pointing to the possibility that TMZ exerts part of its anti-neoplastic action via inhibition of KCa3.1 [17]. This evidence concerns the gene KCNN4 and central nervous system cancer.